Skip to main content
Case Study

Science 37 Accelerates Enrollment for Dermatology Clinical Trial

A biopharma company was conducting a Phase 2 randomized controlled trial in the United States for patients aged 18 and older with mild-to-moderate acne. The sponsor faced challenges with recruiting a diverse and representative patient population as well as study start-up time.

See how the Science 37 Metasite™ enrolled 372 individuals in 7 months, providing 82% patient retention and diversity to meet skin tone requirements by offering at-home participation and flexible treatment options.

Submit the form to watch the case study video.